APPARATUS AND METHOD OF DETECTION AND LOCALIZED TREATMENT OF ABNORMAL CONDITIONS

• US 20100256610A1
• Filed: 10/27/2008
• Published: 10/07/2010
• Est. Priority Date: 10/25/2007
• Status: Abandoned Application

• Current Assignee: The Research Foundation for The State University of New York (State University of New York)
• Original Assignee: The Research Foundation for The State University of New York (State University of New York)
• Inventors: Rigas, Basil
• Application Number:
  US12/739,917
• Publication Number:
  US 20100256610A1
• Time in Patent Office: Days
• US Class Current: 604/891.100
• CPC Class Codes: A61B 2562/08 Sensors provided with means for identification, e.g. barcodes or memory chips
• CPC Class Codes: A61B 5/0031 Implanted circuitry
• CPC Class Codes: A61B 5/4839 combined with drug delivery

Abstract

A method and apparatus for early detection and treatment of abnormal biological activity by specific, localized therapeutic response based on biomarker detection to minimize levels of administrated drugs and reducing toxicity. An external communication device communicates with an implanted probe calibrated to detect a biomarker and an implanted therapeutic delivery system.

Claims

1. An apparatus for detection and targeted treatment of an abnormal condition, the apparatus comprising:

an external communication device;

an implantable probe for biomarker detection and wireless communication with the communication device; and

an implantable therapeutic delivery system that communicates with the external communication device,

wherein, upon biomarker change, a therapeutic agent is delivered by the delivery system.

2. The apparatus of claim 1, wherein the probe is implanted at a specific location within a patient'"'"'s body corresponding to an anticipated biomarker change.

3. The apparatus of claim 1, wherein the delivery system is localized where the probe is implanted.

4. The apparatus of claim 2, wherein the probe and the delivery system are arranged on a single implant.

5. The apparatus of claim 4, wherein the implantable probe is printed onto the delivery system.

6. The apparatus of claim 1, wherein the communication is RFID communication.

7. The apparatus of claim 1, wherein an external monitoring and processing device processes information provided by the probe.

8. The apparatus of claim 1, wherein the detection probe is a nanosensor implanted at time of biopsy or surgery.

9. The apparatus of claim 2, wherein the patient is one of a human patient and a non-human patient.

10. A method of remote detection of abnormal biological activity, the method comprising:

detecting, by an implantable probe, a biomarker;

wirelessly communicating the detection to an external communication device; and

wirelessly communicating between the communication device and an implantable therapeutic delivery system,

wherein the implantable therapeutic delivery system releases a therapeutic agent based on the communication to provide targeted treatment of the abnormal biological activity.

11. The method of claim 10, wherein the probe is implanted at a specific location within a patient'"'"'s body corresponding to anticipated biomarker activity to detect a change in either an amount or activity of the biomarker.

12. The method of claim 10, wherein the delivery system is localized where the probe is implanted.

13. The method of claim 11, wherein the probe and the delivery system are arranged on a single implant.

14. The method of claim 13, wherein the implantable probe is printed onto the delivery system.

15. The method of claim 10, wherein the communication is RFID communication.

16. The method of claim 10, wherein an external monitoring and processing device processes information provided by the probe.

17. The method of claim 10, wherein the detection probe is a nanosensor implanted at time of biopsy or surgery.

18. The method of claim 10, wherein the patient is one of a human patient and a non-human patient.

19. The method of claim 10, wherein implantable probe comprises an RFID tag for wireless communication.

20. An apparatus for detection and targeted treatment of an abnormal condition, the apparatus comprising:

an external communication device;

an implantable probe for detection of the abnormal condition and wireless communication with the communication device; and

an implantable therapeutic delivery system that communicates with the external communication device,

wherein, upon detection, a therapeutic agent is delivered at the site of the abnormal condition.